| ALSA | Community |
|
'EMERGENT TECHNOLOGIES CREATES VALUE USING A UNIQUE TECHNOLOGY INNOVATION PROCESS THAT TRANSFORMS SCIENTIFIC BREAKTHROUGHS INTO TECHNOLOGY PLATFORMS WITH MULTIPLE COMMERCIAL APPLICATIONS. We transform research into revenue using a disciplined selection criteria based primarily upon scientific thought leader sponsorship and a market driven product development process. Our approach unlocks the commercial potential of a scientific breakthrough. In addition, our efficient use of management and capital resources minimizes the economic risk typically associated with developing early stage technologies.' - Emergent Technologies |
| |||
|
'Receptor Logic, Inc. is revolutionizing the field of immunology through our proprietary T-Cell Receptor mimic (TCRm) technology. Receptor Logic’s TCRm technology provides ground breaking opportunity in three business sectors through the following capabilities: 1. Novel platform for therapeutic monoclonal antibodies (mAbs) and associated companion diagnostics; 2. Immunology research reagents available to biomedical research oriented companies and institutions; and 3. Assay development and implementation services supporting T-cell eliciting therapy development and regulatory potency determination.' - Receptor Logic |
| |||
|
(coming soon) |
||||
| (coming soon) | ||||